| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.39▲ | 1.39▲ | 1.39▲ | 1.37▼ | 1.37▼ |
| MA10 | 1.37▲ | 1.38▲ | 1.38▲ | 1.38▼ | 1.48▼ |
| MA20 | 1.38▲ | 1.39▲ | 1.40▲ | 1.40▼ | 1.53▼ |
| MA50 | 1.41▼ | 1.42▼ | 1.42▼ | 1.50▼ | 1.83▼ |
| MA100 | 1.42▼ | 1.42▼ | 1.44▼ | 1.55▼ | 1.24▲ |
| MA200 | 1.44▼ | 1.53▼ | 1.53▼ | 1.76▼ | 1.34▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.008▲ | 0.006▲ | 0.005▲ | 0.001▲ | -0.017▼ |
| RSI | 52.629▲ | 51.648▲ | 51.264▲ | 41.237▼ | 42.663▼ |
| STOCH | 70.139 | 64.630 | 61.019 | 47.965 | 13.679▼ |
| WILL %R | -33.333 | -33.333 | -33.333 | -72.588 | -91.667▼ |
| CCI | 90.690 | 69.934 | 61.843 | -134.974▼ | -88.880 |
|
Thursday, July 09, 2026 05:00 AM
First peer-reviewed publication of chemotherapy-resistant gamma-delta T cells (DeltEx Drug Resistant Immunotherapy or DRI) clinical results in newly diagnosed glioblastoma Repeat-dose patients ...
|
|
Friday, April 03, 2026 01:01 PM
NEW YORK, April 03, 2026 (GLOBE NEWSWIRE)-- IN8bio, Inc. (the "Company") (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative γδ T cell therapies for cancer and autoimmune ...
|
|
Thursday, August 07, 2025 01:26 PM
Net loss (GAAP) narrowed significantly in Q2 2025 due to reduced operational costs, though no revenue was recorded. Clinical trial results for INB-200 in glioblastoma showed a median progression-free ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 17/07/26 | 1.35 | 1.37 | 1.32 | 1.33 | 63,501 |
| 16/07/26 | 1.44 | 1.4624 | 1.38 | 1.38 | 104,984 |
| 15/07/26 | 1.389 | 1.46 | 1.389 | 1.44 | 75,236 |
| 14/07/26 | 1.37 | 1.38 | 1.35 | 1.38 | 16,249 |
| 13/07/26 | 1.32 | 1.38 | 1.32 | 1.34 | 75,092 |
| 10/07/26 | 1.44 | 1.44 | 1.31 | 1.33 | 113,172 |
| 09/07/26 | 1.39 | 1.44 | 1.34 | 1.40 | 69,684 |
| 08/07/26 | 1.40 | 1.44 | 1.35 | 1.38 | 31,383 |
| 07/07/26 | 1.45 | 1.455 | 1.28 | 1.39 | 66,246 |
| 06/07/26 | 1.44 | 1.4599 | 1.39 | 1.44 | 49,118 |
|
|
||||
|
|
||||
|
|